Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on creating a new class of medicines for intracellular targets. The company is advancing a portfolio of genetic medicines for neuromuscular and inherited retinal diseases. Entrada has a collaboration with Vertex Pharmaceuticals for a clinical-stage program for myotonic dystrophy type 1 (DM1). The company anticipates multiple clinical data readouts in 2026 and four clinical-stage programs in its Duchenne muscular dystrophy (DMD) franchise by year-end 2026. Entrada is seeking a Manager, Market Intelligence and Strategy to support the team by synthesizing and communicating strategic insights from market and competitor developments. This role requires an inquisitive spirit, critical thinking, and analytical skills, with a passion for innovative science, data-driven analysis, and strategic insights.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level